With proper care and treatment, diabetes is manageable, but no cure is yet available for this disease. Transforming stem cells into insulin-secreting cells may be the answer to finally curing diabetes.
A recent study, featured in the journal Stem Cell Reports, highlights research from the Washington University School of Medicine in St. Louis, MO. The findings could prove to have a significant impact on the future of patients diagnosed with diabetes.
For many years, scientists have been able to transform stem cells into beta cells (insulin-producing cells), however, they could not measure or regulate how much insulin the new beta cells produced.
Based on updated research and more advanced technologies, researchers have been able to produce beta cells that are more sensitive to blood glucose levels. When transplanted into mice that could not produce insulin, the researchers found these new beta cells started secreting insulin within only a few days but even more exciting, the new beta cells helped control blood sugar levels for months following the transplant.
According to investigators, the new beta cells, or insulin-producing cells, behaved similar to beta cells in healthy people that do not have diabetes.
What kind of Stem Cells could be used for Diabetes?
Mesenchymal stem cells have the potential to treat many chronic diseases, including type 2 diabetes. Mesenchymal stem cells have the ability to differentiate, self-renew, suppress the immune system, reduce inflammation, and repair tissues, making them an ideal treatment option for patients with type 2 diabetes.1
Mesenchymal stem cells have the ability to:
- Differentiate into insulin producing cells
- Restore beta cell function and mass
- Regenerate and protect pancreatic cell
- Convert alpha cell to beta cells
- Reduce inflammation and insulin resistance
Stem Cells Transplant Institute
If you have already been diagnosed with type 2 diabetes, The Stem Cells Transplant Institute in Costa Rica uses mesenchymal stem cells to treat the signs and symptoms of diabetes. Stem cell therapy, at the Stem Cells Transplant Institute, may decrease hyperglycemia (high blood sugar) and the complications associated with hyperglycemia such as diabetic neurophaty, impaired kidney function, heart disease and vision problems.